This popped up in one of my feeds, but I don't think I've seen it discussed before:
https://www.prnewswi...-302656482.html
Immorta Bio Inc., a scientific longevity company dedicated to Treating Diseases of Aging and Treating Aging as Disease™, today announced new data demonstrating that its combination therapy of SenoVax™, a first-in-class senolytic immunotherapy, and personalized mesenchymal stem cells (pMSCs) from its breakthrough StemCellRevivify™ platform, doubled lifespan and significantly extended healthspan in validated murine aging models.
Pretty exciting if it holds up. This is exactly the type of approach I've been waiting for.
